ROHDE-&-SCHWARZ
21.10.2020 15:02:11 CEST | Business Wire | Press release
In the past, the creation of software took about a year on average of development before being commercialized. Today, many organizations are adopting a continuous integration and deployment approach. Now, the cycle has become shorter, thanks in particular to DevOps, which relies on automation and the pooling of complementary skills to increase the added-value and responsiveness of companies.
The Rohde & Schwarz Cybersecurity strategy aims to help DevOps teams integrate application security right from the design phase, by integrating control capabilities within their APIs and applications. Rohde & Schwarz Cybersecurity has been offering Web Application Firewall (WAF) technologies for about twenty years. The company now makes its technologies consumable by developers. It offers tools that integrate into the environment and tools already existing and that use the same languages and technologies of the DevSecOps universe. It is in this context that Rohde & Schwarz Cybersecurity is launching R&S Trusted Application Factory.
Putting security at the heart of applications
R&S Trusted Application Factory is a solution for DevOps teams with the objective of providing security, simplicity and visibility.
- Security : By integrating security as close as possible to the application
- Simplicity : To simplify collaboration, the security solution must be integrated into the DevOps teams' universe. Thus, the same tools, languages and concepts must be used.
- Visibility : It is necessary to provide visibility to the various users and managers: developers, infrastructure and security. R&S Trusted Application Factory tracks the application from design to production execution, providing indicators on its security throughout its lifecycle.
The R&S Trusted Application Factory application security service is deployed as a container for each application. This container can therefore "evolve" at the same time as the application in Kubernetes or Docker clusters. It can therefore automatically adapt to the application load. It also accompanies the application and can be deployed on-demand as well as on the private or public cloud. All the services are managed from a SaaS administration console, which enables the security of the various applications to be monitored.
The solution is based on the concept of "Context Description" to improve the level of security. Indeed, the data specific to each application and available to the development teams are essential for the configuration of security. The type of persistence used, the programming language, the server operating system and the data formats make it possible to automatically adapt protection policies by invoking the appropriate engines. By taking all these elements into account, increased security and a reduced risk of false positives is achieved.
Rohde & Schwarz Cybersecurity
Rohde & Schwarz Cybersecurity is a leading IT security company that protects the digital assets of companies and public institutions worldwide from cyberattacks.
Rohde & Schwarz
Rohde & Schwarz is a leading supplier of solutions in the fields of test and measurement, broadcast and media, aerospace | defense | security and networks and cybersecurity.
R&S® is a registered trademark of Rohde & Schwarz GmbH & Co KG.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201021005500/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom